Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 1;15(1):3-10.
doi: 10.1097/SPC.0000000000000539.

Predicting treatment toxicity in older adults with cancer

Affiliations
Review

Predicting treatment toxicity in older adults with cancer

Ines B Menjak et al. Curr Opin Support Palliat Care. .

Abstract

Purpose of review: To provide an overview of the recent advancements in predicting toxicity associated with cancer treatment in older patients.

Recent findings: Various screening tools and validated risk calculators have been shown to help predict toxicity from surgery and chemotherapy. Radiation therapy has been more challenging to select the appropriate tool to reliably predict patients at risk for toxicity and noncompliance. Ongoing work on electronic geriatric assessment tools is showing promise in making comprehensive assessment more feasible.

Summary: Selecting appropriate cancer therapy is particularly important in older patients, and validated tools have been developed to guide clinicians for surgery and chemotherapy; however, radiotherapy toxicity remains an area for further development, as does the uptake of existing tools into routine oncology practice.

PubMed Disclaimer

References

    1. United Nations Department of Economic and Social Affairs. United Nations Department of Economic and Social affairs, Population Division. World population prospects: the 2015 revision, key findings and advance tables. Technical report: working paper no ESA/P/WP 241. New York, NY: United Nations Department of Economic and Social Affairs; 2015.
    1. Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer 2019; 144:49–58.
    1. Corbett T, Bridges J. Multimorbidity in older adults living with and beyond cancer. Curr Opin Support Palliat Care 2019; 13:220–224.
    1. Hakozaki T, Matsuo T, Shimizu A, et al. Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors. J Geriatr Oncol 2020; 12:64–71.
    1. Stout NL, Wagner SS. Antineoplastic therapy side effects and polypharmacy in older adults with cancer. Top Geriatr Rehabil 2019; 35:15–30.